{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:01:23Z","timestamp":1789066883823,"version":"build-2803163510"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/jcp.0b013e3182217a50","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T02:49:40Z","timestamp":1308624580000},"page":"441-448","source":"Crossref","is-referenced-by-count":14,"title":["Absence of Psychostimulant Effects of a Supratherapeutic Dose of Tianeptine"],"prefix":"10.1097","volume":"31","author":[{"given":"Katy","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Penelaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Moca\u00ebr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Donazzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000119326","article-title":"Placebo-controlled study of tianeptine in major depressive episodes.","volume":"35","author":"Costa e Silva","year":"1997","journal-title":"Neuropsychobiology"},{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-0327(99)00009-9","article-title":"Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine.","volume":"56","author":"Loo","year":"1999","journal-title":"J Affect Disord"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hup.289","article-title":"Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study dagger.","volume":"16","author":"Lepine","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hup.411","article-title":"Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study.","volume":"17","author":"Novotny","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"R5-7-20210128","first-page":"343","article-title":"Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression in French.","volume":"28","author":"Szadoczky","year":"2002","journal-title":"Encephale"},{"key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00023210-200216010-00005","article-title":"Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.","volume":"16","author":"Waintraub","year":"2002","journal-title":"CNS Drugs"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","article-title":"Clinical and neurobiological effects of tianeptine and paroxetine in major depression.","volume":"23","author":"Nickel","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R8-7-20210128","first-page":"322","article-title":"A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression in French.","volume":"29","author":"Olie","year":"2003","journal-title":"Encephale"},{"issue":"suppl 3","key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0924-9338(02)00651-X","article-title":"A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.","volume":"17","author":"Kasper","year":"2002","journal-title":"Eur Psychiatry"},{"issue":"suppl 4","key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/S0924-977X(03)91842-6","article-title":"First signs of improvement with tianeptine in the treatment of depression: an analysis of a double-blind study versus fluoxetine abstract.","volume":"13","author":"Novotny","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"issue":"suppl 2","key":"R11-7-20210128","first-page":"S97","article-title":"Position of tianeptine among antidepressive chemotherapies.","volume":"11","author":"Loo","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000118590","article-title":"Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline.","volume":"22","author":"Guelfi","year":"1989","journal-title":"Neuropsychobiology"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000119142","article-title":"The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline.","volume":"30","author":"Invernizzi","year":"1994","journal-title":"Neuropsychobiology"},{"key":"R14-7-20210128","first-page":"461","article-title":"Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin in French.","volume":"25","author":"Brion","year":"1996","journal-title":"Presse Med"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130000662","article-title":"Effects of tianeptine and mianserin on car driving skills.","volume":"154","author":"Ridout","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00023210-200115030-00006","article-title":"Tianeptine: a review of its use in depressive disorders.","volume":"15","author":"Wagstaff","year":"2001","journal-title":"CNS Drugs"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00003495-199549030-00007","article-title":"Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.","volume":"49","author":"Wilde","year":"1995","journal-title":"Drugs"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.479","article-title":"Switching to tianeptine in patients with antidepressant-induced sexual dysfunction.","volume":"18","author":"Atmaca","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1185\/030079902125001461","article-title":"The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France.","volume":"19","author":"Bonierbale","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation.","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1460-9568.2002.02136.x","article-title":"The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats.","volume":"16","author":"Kole","year":"2002","journal-title":"Eur J Neurosci"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1111\/j.1460-9568.2007.05560.x","article-title":"Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment.","volume":"25","author":"Reznikov","year":"2007","journal-title":"Eur J Neurosci"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1073\/pnas.0307294101","article-title":"Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine.","volume":"101","author":"Reagan","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1111\/j.1460-9568.2007.05952.x","article-title":"Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine.","volume":"26","author":"Svenningsson","year":"2007","journal-title":"Eur J Neurosci"},{"key":"R26-7-20210128","first-page":"72","article-title":"A case of tianeptine abuse in Turkish.","volume":"17","author":"Saatcioglu","year":"2006","journal-title":"Turk Psikiyatri Derg"},{"key":"R27-7-20210128","first-page":"672","article-title":"Abuse of tianeptine. A case report in French.","volume":"25","author":"Vandel","year":"1999","journal-title":"Encephale"},{"issue":"suppl 2","key":"R28-7-20210128","first-page":"S43","article-title":"Neurochemical profile of tianeptine, a new antidepressant drug.","volume":"11","author":"Kato","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0924933800002923","article-title":"Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo.","volume":"8","author":"Warot","year":"1993","journal-title":"Eur Psychiatry"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference.","volume":"14","author":"Jasinski","year":"2000","journal-title":"J Psychopharmacol"},{"key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1064-1297.15.2.123","article-title":"Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.","volume":"15","author":"Makris","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"R32-7-20210128","first-page":"307","article-title":"Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.","volume":"50","author":"Warot","year":"1995","journal-title":"Therapie"},{"key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(02)00053-4","article-title":"Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.","volume":"67","author":"Heil","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2008.01.008","article-title":"Abuse liability assessment of atomoxetine in a drug-abusing population.","volume":"95","author":"Jasinski","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/S1461145708009097","article-title":"Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.","volume":"11","author":"Newton","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130050001","article-title":"Abuse liability assessment of sibutramine, a novel weight control agent.","volume":"147","author":"Schuh","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.1992.202","article-title":"Psychoactivity and abuse potential of sumatriptan.","volume":"52","author":"Sullivan","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ebmh.12.1.18","article-title":"Review: methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms.","volume":"12","author":"Jensen","year":"2009","journal-title":"Evid Based Ment Health"},{"key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-200106000-00005","article-title":"Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.","volume":"21","author":"Rush","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R41-7-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.jcp.0000084023.22282.03","article-title":"Neurochemical and psychotropic effects of bupropion in healthy male subjects.","volume":"23","author":"Gobbi","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R42-7-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2125.1983.tb01512.x","article-title":"Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers.","volume":"15","author":"Hamilton","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"R43-7-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00429009","article-title":"Assessment of dependence potential of drugs in humans using multiple indices.","volume":"81","author":"Johanson","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"R44-7-20210128","first-page":"202","article-title":"Psychopharmacology of bupropion in normal volunteers.","volume":"44","author":"Peck","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"R45-7-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hup.456","article-title":"Modafinil affects mood, but not cognitive function, in healthy young volunteers.","volume":"18","author":"Randall","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"R46-7-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0013-4694(81)90101-2","article-title":"Effect of methylphenidate on young adult's vigilance and event-related potentials.","volume":"51","author":"Coons","year":"1981","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R47-7-20210128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.668","article-title":"Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.","volume":"20","author":"Lee","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"R48-7-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02584088","article-title":"Development of the Addiction Research Center Inventory (ARCI): selection of items that are sensitive to the effects of various drugs.","volume":"4","author":"Haertzen","year":"1963","journal-title":"Psychopharmacologia"},{"key":"R49-7-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02584089","article-title":"The Addiction Research Center Inventory: standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol, LSD-25, pryrahexyl and chlorpromazine.","volume":"4","author":"Hill","year":"1963","journal-title":"Psychopharmacologia"},{"key":"R50-7-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man.","volume":"12","author":"Martin","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"R51-7-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00735818","article-title":"Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review.","volume":"47","author":"Smith","year":"1976","journal-title":"Psychopharmacologia"},{"key":"R52-7-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","article-title":"Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.","volume":"6","author":"Rush","year":"1998","journal-title":"Exp Clin Psychopharmacol"},{"key":"R53-7-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008877-199406000-00005","article-title":"Reinforcing and subjective effects of methylphenidate in humans.","volume":"5","author":"Chait","year":"1994","journal-title":"Behav Pharmacol"},{"issue":"suppl 11","key":"R54-7-20210128","first-page":"14","article-title":"Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.","volume":"64","author":"Kollins","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R55-7-20210128","first-page":"5","article-title":"Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats.","volume":"50","author":"Nowakowska","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"R56-7-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0376-8716(03)00131-5","article-title":"Reinforcing, subject-rated, and physiological effects of intranasal methylphenidate in humans: a dose-response analysis.","volume":"71","author":"Stoops","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R57-7-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004714-199806000-00008","article-title":"Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines.","volume":"18","author":"Cole","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R58-7-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"R59-7-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","article-title":"Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.","volume":"23","author":"Jasinski","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"R60-7-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00436152","article-title":"A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers.","volume":"80","author":"Miller","year":"1983","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201108000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:31:54Z","timestamp":1786044714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201108000-00007"}},"subtitle":["A Placebo-Controlled Study Versus Methylphenidate in Young Healthy Volunteers"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182217a50","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}